Charles Gasparino
Charlie Gasparino is CNBC's on-air editor. Gasparino often breaks major Wall Street news involving mergers and acquisitions, investigations into corporate crime, and company management changes.
Gasparino previously worked at Newsweek and at The Wall Street Journal.
Gasparino is the author of Blood on the Street.
View Older Stories View More Recent Stories
-
Tesla (TSLA) officials could meet with SEC this week - FBN
-
SEC under pressure to move quickly with its Tesla (TSLA) investigation - FBN
-
Tesla (TSLA) legal team bracing for billions of dollars in potential liability from private lawsuits over tweet - FBN
-
SEC officials worried about impact of investigation on Tesla's )TSLA) ability to go private - FBN
-
SEC ramps up investigation into Tesla (TSLA) privatization plans - FBN
-
Tribune Media (TRCO) Mulls Pulling out of Sinclair Broadcast Group (SBGI) Deal - FBN
-
Sinclair Broadcast Group (SBGI) expecting imminent DOJ approval of $3.9b deal for Tribune (TRCO) - FBN
-
DOJ/FCC Could Rule on Sinclair Broadcast Group (SBGI)/Tribune Media (TRCO) as Soon as Friday - FBN
-
21st Century Fox (FOXA) Execs Brace for Improved Comcast (CMCSA) Bid for Fox Assets - FBN
-
CNBC Story on AT&T (T) and Time Warner (TWX) is Inaccurate, Gov. Can Still File Appeal - FBN
-
DOJ Could File its Appeal to Time Warner (TWX)/ AT&T (T) Today - FBN
-
Comcast (CMCSA) Executives Told to Expect Protracted Struggle for Fox (FOXA) Assets, Resistance to Hostile Bid from DOJ, Fox Management - FBN
-
General Electric (GE) Said to have Multiple Bidders for Lighting Business, Could Fetch $1B - FBN
-
General Electric (GE) Spokesman Wouldn't Deny Dividend Could be Cut - FBN
-
General Electric (GE) Considering Further Dividend Cut, Elimination - Fox
-
CBS Corp. (CBS) and Viacom (VIAB) Agree to Quietly Negotiate Possible Merger - FBN
-
FBN's Gasparino Tweets Chatter that Rosenstein is 'Out'
-
Goldman Sachs' (GS) Blankfein May Give Up Chairman Role - FBN
-
Gary Cohn Told People He's Likely to Stay - FBN
-
UPDATE: Twitter (TWTR) is Shopping Itself - FBN
-
DOJ Compiling Witness List in AT&T (T), Time Warner (TWX) Suit - FBN
-
DOJ Antitrust Signals Attempt to Block TWX (TWX) /AT&T (T) Does Not Effect Possible Media Deals Like FOX (FOXA) /Disney (DIS) - FBN
-
GE's (GE) Open Board Seat Could be Filed by Nelson Peltz - FBN
-
General Electric (GE) Near Decision to Give Peltz's Train Management Board Seat - Gasparino
-
Twitter (TWTR) Ticks Higher on Renewed Takeover Chatter
-
Twitter (TWTR) on Watch Following Tweet from Gasparino
-
Steve Bannon Tells Associates his Job is Safe in Short Term - FBN's Gasparino
-
General Electric (GE) Considering Additional Assets Sales - Gasparino
-
Verizon (VZ) CEO McAdam Says Has No Intention to Buy Disney (DIS) - Fox
-
Freedom Caucus Walks out of White House w/o Agreement, No Comment to Reporters - GASPARINO FBN
-
Time Warner (TWX) puts active on Steve Bannon still opposed to AT&T, Time Warner deal, FBN's Gasparino says
-
General Electric (GE) on Watch Following Gasparino Tweet
-
Twitter (TWTR) Gains After Announcing Update on Efforts to End Harassment; Earnings Loom
-
UPDATE: Twitter (TWTR) Shows Strength Into Market Close Following Gasparino Tweet
-
Time Warner (TWX) Ticks Higher as FBN Reports Bankers Expect Trump Admin Deal Approval
-
JPMorgan CEO Dimon still part of Trump Treasury talk
-
Twitter (TWTR) Will be Sold, Question is Price - FBN
-
FOX Business Network Delivers Highest Rated Presidential Debate in Network History
-
Herbalife (HLF) said to draft lawsuit against Ackman - FBN's Gasparino
-
Herbalife (HLF) Says Icahn Isn't Paring Stake - FBN
-
UPDATE: Monsanto (MON) Bankers Bracing for New Bayer Announcement - FBN
-
UPDATE: Bayer's Meeting With Investors Suggests High Bid Coming for Monsanto (MON) - FBN
-
Bayer Unlikely to Up bid Much for Monsanto (MON) - FBN
-
Monsanto (MON) said to expect a Bayer counteroffer - FBN's Gasparino
-
Herbalife (HLF): reports of imminent deal w FTC 'not true' - Gasparino
-
Herbalife (HLF), FTC Close to Deal - Gasparino Tweet
-
Munger Says Ackman is 'Totally Right' About Herbalife (HLF) - FBN
-
Valeant Pharma (VRX) said still discussing possible sale of Bausch + Lomb - Fox News
-
UPDATE: Valeant Pharma (VRX) Said Actively Discussing Sale of Bausch + Lomb Unit
-
Virgin America (VA) Sale Could Come on Monday, Says FBN's Gasparino

